SCHEMBL19212937

SCHEMBL19212937

C=C(Oc1ccc(Cl)cc1)C(=O)c1ccc(SC)cc1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.65
CYP11B2 P19099 3/20 0.65
MAPT P10636 6/20 0.43
KMT2A Q03164 5/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 3/20 0.41
FLT1 P17948 2/20 0.41
FLT4 P35916 2/20 0.41
KDR P35968 2/20 0.41
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 1/20 0.39
PTGS2 P35354 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19213004 0.87 CYP11B1 (0.51) CYP11B1CYP11B2MAPTKMT2ALMNA
SCHEMBL26813754 0.81 CYP11B1 (0.48) CYP11B1CYP11B2MAPTKMT2ALMNA
SCHEMBL17723970 0.79 CYP11B1 (1.00) CYP11B1CYP11B2
SCHEMBL19212998 0.76 CYP11B1 (0.58) CYP11B1CYP11B2KMT2AHPGDRAB9A
SCHEMBL19212916 0.74 ABCG2 (0.56) CYP11B1CYP11B2MAPTKMT2ALMNA
SCHEMBL19212936 0.73 CYP11B1 (0.60) CYP11B1CYP11B2MAPTKMT2ALMNA
SCHEMBL26813738 0.72 CYP11B1 (0.52) CYP11B1CYP11B2MAPTLMNARAB9A
SCHEMBL19212921 0.71 CYP11B1 (0.63) CYP11B1CYP11B2MAPTKMT2ALMNA
SCHEMBL19213000 0.71 CYP11B1 (0.62) CYP11B1CYP11B2LMNARAB9ANPC1
SCHEMBL19212992 0.70 CES2 (0.56) CYP11B1CYP11B2MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212636-B1 NEW PYRIDINYLOXY- AND PHENYLOXY-PYRAZOLYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2023-11-29 EP disclosed
US-9790217-B2 Pyridinyloxy- and phenyloxy-pyrazolyl compounds HOFFMANN-LA ROCHE INC. (US) 2017-10-17 US disclosed
US-20170226097-A1 PYRIDINYLOXY- AND PHENYLOXY-PYRAZOLYL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226097-A1 PYRIDINYLOXY- AND PHENYLOXY-PYRAZOLYL COMPOUNDS PDXK, PNPO, PAH CYP11B1 84/4885CYP11B2 32/4885MAPT 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.